Default company panoramic image
E60c32df f4fb 49e1 8db2 b9ca8a25e7e4

Gypsy Bay Genomics, Inc.

Accelerating the Fight Against Global HPV Cancers

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded November 2018
  • Employees 2
  • Incorporation Type C-corp
  • Website

Company Summary

Gypsy Bay Genomics is a DOD spinout commercializing the Molecular Pap, a diagnostic that detects cervical cancer caused by the sexually transmitted virus HPV. Our technology is designed to be accurate, automatable, low cost, and complementary to self-sampling methods applicable to any anatomical site. Our ultimate goal is to offer an FDA approved test that is simple, personal, affordable, and easily available for the improvement of global health.